iSpecimen Inc. Amortization of Intangible Assets
iSpecimen Inc. (ISPC) reported Amortization of Intangible Assets of $191.56 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-01.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-14
- iSpecimen Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $47.89K, a 0.00% change year-over-year.
- iSpecimen Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $47.89K, a 0.00% change year-over-year.
- iSpecimen Inc. amortization of intangible assets for the quarter ending 2025-06-30 was $47.89K, a 0.00% increase year-over-year.
- iSpecimen Inc. amortization of intangible assets for the quarter ending 2025-03-31 was $47.89K, a 0.00% decline year-over-year.
- iSpecimen Inc. amortization of intangible assets for fiscal 2025 was $191.56K, a 0.00% change from fiscal 2024.
- iSpecimen Inc. amortization of intangible assets for fiscal 2024 was $191.56K, a 286.82% increase from fiscal 2023.
- iSpecimen Inc. amortization of intangible assets for fiscal 2023 was $49.52K, a 95.81% decline from fiscal 2022.
- iSpecimen Inc. amortization of intangible assets for fiscal 2022 was $1.18M, a 23.38% increase from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | $47.89K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $95.78K derived: sum of 2 quarters · filed 2026-04-01 | $143.67K derived: sum of 3 quarters · filed 2026-08-14 | $191.56K 10-K · filed 2026-04-01 | ||
| 2025-09-30 | $47.89K 10-Q · filed 2025-11-17 | $95.78K derived: sum of 2 quarters · filed 2026-08-14 | $143.67K 10-Q · filed 2025-11-17 | $191.56K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $47.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $95.78K 10-Q · filed 2026-08-14 | $143.67K derived: sum of 3 quarters · filed 2026-08-14 | $191.56K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $47.89K 10-Q · filed 2026-05-18 | $95.78K derived: sum of 2 quarters · filed 2026-05-18 | $143.67K derived: sum of 3 quarters · filed 2026-05-18 | $191.55K derived: sum of 4 quarters · filed 2026-05-18 | ||
| 2024-12-31 | $47.89K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $95.78K derived: sum of 2 quarters · filed 2026-04-01 | $143.67K derived: sum of 3 quarters · filed 2026-04-01 | $191.56K 10-K · filed 2026-04-01 | ||
| 2024-09-30 | $47.89K 10-Q · filed 2025-11-17 | $95.78K derived: sum of 2 quarters · filed 2025-11-17 | $143.67K 10-Q · filed 2025-11-17 | $186.80K derived: sum of 4 quarters · filed 2025-11-17 | ||
| 2024-06-30 | $47.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $95.78K 10-Q · filed 2025-08-14 | $138.91K derived: sum of 3 quarters · filed 2025-08-14 | $145.30K derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $47.89K 10-Q · filed 2025-05-19 | $91.03K derived: sum of 2 quarters · filed 2025-05-19 | $97.41K derived: sum of 3 quarters · filed 2025-05-19 | $97.41K derived: sum of 4 quarters · filed 2025-05-19 | ||
| 2023-12-31 | $43.14K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-14 | $49.52K derived: sum of 2 quarters · filed 2025-04-14 | $49.52K derived: sum of 3 quarters · filed 2025-04-14 | $49.52K 10-K · filed 2025-04-14 | ||
| 2023-09-30 | $6.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $6.38K derived: sum of 2 quarters · filed 2024-11-07 | $6.38K 10-Q · filed 2024-11-07 | $363.35K derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | $934.83K 10-Q · filed 2023-08-02 | $356.96K derived: sum of 3 quarters · filed 2024-08-06 | $649.65K derived: sum of 4 quarters · filed 2024-08-06 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-07 | $433.33K 10-Q · filed 2023-05-04 | $356.96K derived: sum of 2 quarters · filed 2024-05-07 | $649.65K derived: sum of 3 quarters · filed 2024-05-07 | $916.55K derived: sum of 4 quarters · filed 2024-05-07 | |
| 2022-12-31 | $356.96K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-30 | $649.65K derived: sum of 2 quarters · filed 2023-03-30 | $916.55K derived: sum of 3 quarters · filed 2023-08-02 | $1.18M 10-K/A · filed 2023-03-30 | ||
| 2022-09-30 | $292.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $559.59K derived: sum of 2 quarters · filed 2023-08-02 | $825.80K 10-Q · filed 2022-11-08 | $1.07M derived: sum of 4 quarters · filed 2023-08-02 | ||
| 2022-06-30 | $266.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $533.11K 10-Q · filed 2023-08-02 | $777.31K derived: sum of 3 quarters · filed 2023-08-02 | $1.02M derived: sum of 4 quarters · filed 2023-08-02 | ||
| 2022-03-31 | $266.22K 10-Q · filed 2023-05-04 | $510.41K derived: sum of 2 quarters · filed 2023-05-04 | $753.27K derived: sum of 3 quarters · filed 2023-05-04 | $989.63K derived: sum of 4 quarters · filed 2023-05-04 | ||
| 2021-12-31 | $244.19K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-30 | $487.06K derived: sum of 2 quarters · filed 2023-03-30 | $723.41K derived: sum of 3 quarters · filed 2023-03-30 | $958.64K 10-K/A · filed 2023-03-30 | ||
| 2021-09-30 | $242.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $479.21K derived: sum of 2 quarters · filed 2022-11-08 | $714.44K 10-Q · filed 2022-11-08 | $889.95K derived: sum of 4 quarters · filed 2022-11-08 | ||
| 2021-06-30 | $236.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $471.58K 10-Q · filed 2022-08-04 | $647.09K derived: sum of 3 quarters · filed 2022-08-04 | $826.26K derived: sum of 4 quarters · filed 2022-08-04 | ||
| 2021-03-31 | $235.23K 10-Q · filed 2022-05-10 | $410.73K derived: sum of 2 quarters · filed 2022-05-10 | $589.90K derived: sum of 3 quarters · filed 2022-05-10 | |||
| 2020-12-31 | $175.50K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $354.67K derived: sum of 2 quarters · filed 2022-03-22 | $774.93K 10-K · filed 2022-03-22 | |||
| 2020-09-30 | $179.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $599.42K 10-Q · filed 2021-11-04 | ||||
| 2020-06-30 | $420.26K 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |